Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication
The facility is among 12 centres established worldwide, and the first in Asia
ABDM is a critical integration that leverages an open, interoperable, standards-based digital system that is secure, and maintains confidentiality and privacy of health-related personal information
The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023
Avacc 3 has significant advantages over existing whooping cough vaccines
He will be leading the business, operations, P&L, and growth strategy for StanPlus
State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May
Pharma exports in 2021-22 sustain a positive growth despite global trade disruptions
South Carolina’s largest health system adopts Philips software solutions for patient monitoring and enterprise imaging, helping to drive interoperability and data analytics, and deliver on Quadruple Aim
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study
Subscribe To Our Newsletter & Stay Updated